{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:11:03Z","timestamp":1792649463814,"version":"4.5.0"},"reference-count":29,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["NIHR131211"],"award-info":[{"award-number":["NIHR131211"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Pract Neurol"],"accepted":{"date-parts":[[2025,11,5]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>This opinion piece discusses the challenges of managing a person with sight-threatening papilloedema due to idiopathic intracranial hypertension (IIH). With no available randomised controlled trials, clinicians often choose a locally available surgical intervention. An increasing number of studies have advocated using dural venous sinus stenting in IIH. Big data studies show that shunts have been the mainstay of surgical treatment for IIH, and recent evidence shows improved outcomes and fewer revision surgeries. There remains genuine equipoise in the choice of intervention between shunting and dural venous stenting in IIH. The IIH Intervention Trial funded by the National Institute of Health Research is underway in the UK, the first randomised control trial to evaluate both of these surgical interventions in people with sight-threatening IIH.<\/jats:p>","DOI":"10.1136\/pn-2025-004728","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T06:00:22Z","timestamp":1765432822000},"page":"142-145","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Stenting versus shunting in sight-threatening idiopathic intracranial hypertension: genuine equipoise"],"prefix":"10.1136","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6314-4437","authenticated-orcid":false,"given":"Susan P","family":"Mollan","sequence":"first","affiliation":[{"name":"Metabolism and Systems Science, University of Birmingham, Birmingham, UK"},{"name":"Department of Ophthalmology, Queen\u2019s University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Tsermoulas","sequence":"additional","affiliation":[{"name":"Neurosurgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3390-9508","authenticated-orcid":false,"given":"Gabriele","family":"Berman","sequence":"additional","affiliation":[{"name":"Birmingham Neuro-ophthalmology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed K","family":"Toma","sequence":"additional","affiliation":[{"name":"Victor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robertson","family":"Fergus","sequence":"additional","affiliation":[{"name":"Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"White","sequence":"additional","affiliation":[{"name":"Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin R","family":"Wakerley","sequence":"additional","affiliation":[{"name":"Metabolism and Systems Science, University of Birmingham, Birmingham, UK"},{"name":"Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2777-5132","authenticated-orcid":false,"given":"Alexandra J","family":"Sinclair","sequence":"additional","affiliation":[{"name":"Metabolism and Systems Science, University of Birmingham, Birmingham, UK"},{"name":"Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"2026031600451065000_26.2.142.1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41582-023-00893-0","article-title":"Idiopathic intracranial hypertension: a step change in understanding the disease mechanisms","volume":"19","author":"Yiangou","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"2026031600451065000_26.2.142.2","doi-asserted-by":"crossref","DOI":"10.3390\/life11050417","article-title":"Idiopathic Intracranial Hypertension: Evaluation of Admissions and Emergency Readmissions through the Hospital Episode Statistic Dataset between 2002-2020","volume":"11","author":"Mollan","year":"2021","journal-title":"Life"},{"key":"2026031600451065000_26.2.142.3","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-317440"},{"key":"2026031600451065000_26.2.142.4","doi-asserted-by":"publisher","DOI":"10.1227\/neu.0000000000002718"},{"key":"2026031600451065000_26.2.142.5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/01658107.2014.956183","article-title":"Visual Outcomes from Shunting for Idiopathic Intracranial Hypertension","volume":"38","author":"Hickman","year":"2014","journal-title":"Neuroophthalmology"},{"key":"2026031600451065000_26.2.142.6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/EB.S193027","article-title":"Exploring The Current Management Idiopathic Intracranial Hypertension, And Understanding The Role Of Dural Venous Sinus Stenting","volume":"12","author":"Gurney","year":"2020","journal-title":"Eye Brain"},{"key":"2026031600451065000_26.2.142.7","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00701-024-06345-y","article-title":"Effectiveness of optic nerve sheath fenestration in preserving vision in idiopathic intracranial hypertension: an updated meta-analysis and systematic review","volume":"166","author":"Prokop","year":"2024","journal-title":"Acta Neurochir (Wien)"},{"key":"2026031600451065000_26.2.142.8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1227\/neu.0000000000002086","article-title":"Cerebrospinal Fluid Shunting for Idiopathic Intracranial Hypertension: A Systematic Review, Meta-Analysis, and Implications for a Modern Management Protocol","volume":"91","author":"Salih","year":"2022","journal-title":"Neurosurgery"},{"key":"2026031600451065000_26.2.142.9","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00701-017-3229-6","article-title":"Effect of venous stenting on intracranial pressure in idiopathic intracranial hypertension","volume":"159","author":"Matloob","year":"2017","journal-title":"Acta Neurochir (Wien)"},{"key":"2026031600451065000_26.2.142.10","doi-asserted-by":"crossref","first-page":"3331024231197118","DOI":"10.1177\/03331024231197118","article-title":"Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension","volume":"43","author":"Mollan","year":"2023","journal-title":"Cephalalgia"},{"key":"2026031600451065000_26.2.142.11","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00415-022-11402-6","article-title":"The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomes","volume":"270","author":"Thaller","year":"2023","journal-title":"J Neurol"},{"key":"2026031600451065000_26.2.142.12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/WNO.0000000000001902","article-title":"Common Design and Data Elements Reported on Idiopathic Intracranial Hypertension Trials: A Systematic Review","volume":"44","author":"Kobeissi","year":"2024","journal-title":"J Neuroophthalmol"},{"key":"2026031600451065000_26.2.142.13","doi-asserted-by":"crossref","unstructured":"Patsalides A , Fargen KM , Davies JM , et al . The River study: the first prospective multicenter trial of a novel venous sinus stent for the treatment of idiopathic intracranial hypertension. J Neurointerv Surg 2025. doi:10.1136\/jnis-2024-022540","DOI":"10.1136\/jnis-2024-022540"},{"key":"2026031600451065000_26.2.142.14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.wneu.2022.08.154","article-title":"The Birmingham Standardized Idiopathic Intracranial Hypertension Shunt Protocol: Technical Note","volume":"167","author":"Tsermoulas","year":"2022","journal-title":"World Neurosurg"},{"key":"2026031600451065000_26.2.142.15","unstructured":"Surgical Idiopathic Intracranial Hypertension Treatment Trial (SIGHT) ClinicalTrials.gov ID NCT03501966 . Available: https:\/\/clinicaltrials.gov\/study\/NCT03501966#study-overview [Accessed 6 Oct 2025]."},{"key":"2026031600451065000_26.2.142.16","doi-asserted-by":"crossref","unstructured":"IIH intervention: a clinical trial comparing two treatments (shunts and stents) to preserve vision for people with idiopathic intracranial hypertension. ISRCTN57142415. 2025. Available: https:\/\/doi.org\/10.1186\/ISRCTN57142415 [Accessed 6 Oct 2025].","DOI":"10.1186\/ISRCTN57142415"},{"key":"2026031600451065000_26.2.142.17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3312"},{"key":"2026031600451065000_26.2.142.18","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jamaneurol.2021.0659","article-title":"Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension: A Randomized Clinical Trial","volume":"78","author":"Mollan","year":"2021","journal-title":"JAMA Neurol"},{"key":"2026031600451065000_26.2.142.19","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad003"},{"key":"2026031600451065000_26.2.142.20","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000251312.19452.ec"},{"key":"2026031600451065000_26.2.142.21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/01658107.2024.2337165","article-title":"Fulminant Idiopathic Intracranial Hypertension Should Be Redefined Without a Time Limited Definition: In reply to: Characterisation and visual outcomes of fulminant idiopathic intracranial hypertension: a narrative review","volume":"48","author":"Menon","year":"2024","journal-title":"Neuroophthalmology"},{"key":"2026031600451065000_26.2.142.22","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01321-8"},{"key":"2026031600451065000_26.2.142.23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/head.14026","article-title":"Erenumab for headaches in idiopathic intracranial hypertension: A prospective open-label evaluation","volume":"61","author":"Yiangou","year":"2021","journal-title":"Headache"},{"key":"2026031600451065000_26.2.142.24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ajo.2023.01.016","article-title":"Defining the Phenotype and Prognosis of People With Idiopathic Intracranial Hypertension After Cerebrospinal Fluid Diversion Surgery","volume":"250","author":"Hyder","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"2026031600451065000_26.2.142.25","article-title":"Infographic: landmark trials in neuro-ophthalmology-results of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT)","author":"Lowe","year":"2025","journal-title":"Eye (Lond)"},{"key":"2026031600451065000_26.2.142.26","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab202","article-title":"Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure","volume":"3","author":"Grech","year":"2021","journal-title":"Brain Commun"},{"key":"2026031600451065000_26.2.142.27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/tvst.12.5.1","article-title":"Visual Field Pointwise Analysis of the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT)","volume":"12","author":"Mollan","year":"2023","journal-title":"Transl Vis Sci Technol"},{"key":"2026031600451065000_26.2.142.28","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/jamaophthalmol.2020.4242","article-title":"Using Optical Coherence Tomography as a Surrogate of Measurements of Intracranial Pressure in Idiopathic Intracranial Hypertension","volume":"138","author":"Vijay","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"2026031600451065000_26.2.142.29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11910-025-01420-y","article-title":"Current Understanding of the Pathophysiology of Idiopathic Intracranial Hypertension","volume":"25","author":"Lowe","year":"2025","journal-title":"Curr Neurol Neurosci Rep"}],"container-title":["Practical Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/pn-2025-004728","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T07:45:57Z","timestamp":1773647157000},"score":1,"resource":{"primary":{"URL":"https:\/\/pn.bmj.com\/lookup\/doi\/10.1136\/pn-2025-004728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,3,13]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/pn-2025-004728"],"URL":"https:\/\/doi.org\/10.1136\/pn-2025-004728","relation":{},"ISSN":["1474-7758","1474-7766"],"issn-type":[{"value":"1474-7758","type":"print"},{"value":"1474-7766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]}}}